These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32751220)

  • 1. Sex-Specific Prognostic Implications in Dilated Cardiomyopathy After Left Ventricular Reverse Remodeling.
    Cannata A; Manca P; Nuzzi V; Gregorio C; Artico J; Gentile P; Pio Loco C; Ramani F; Barbati G; Merlo M; Sinagra G
    J Clin Med; 2020 Jul; 9(8):. PubMed ID: 32751220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time course of left ventricular reverse remodeling in response to pharmacotherapy: clinical implication for heart failure prognosis in patients with idiopathic dilated cardiomyopathy.
    Ikeda Y; Inomata T; Iida Y; Iwamoto-Ishida M; Nabeta T; Ishii S; Sato T; Yanagisawa T; Mizutani T; Naruke T; Koitabashi T; Takeuchi I; Nishii M; Ako J
    Heart Vessels; 2016 Apr; 31(4):545-54. PubMed ID: 25686768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Phenotype and Genotype Associations With Improvement in Left Ventricular Function in Dilated Cardiomyopathy.
    Verdonschot JAJ; Hazebroek MR; Wang P; Sanders-van Wijk S; Merken JJ; Adriaansen YA; van den Wijngaard A; Krapels IPC; Brunner-La Rocca HP; Brunner HG; Heymans SRB
    Circ Heart Fail; 2018 Nov; 11(11):e005220. PubMed ID: 30571196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes and reverse remodelling in recently diagnosed unexplained left ventricular systolic dysfunction.
    Kuchynka P; Podzimkova J; Marek J; Danek BA; Vitkova I; Kreidlova M; Roblova L; Kovarnik T; Simek S; Horak J; Habasko J; Linhart A; Palecek T
    ESC Heart Fail; 2024 Apr; 11(2):859-870. PubMed ID: 38204216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Big Endothelin-1 as a Predictor of Reverse Remodeling and Prognosis in Dilated Cardiomyopathy.
    Feng J; Liang L; Chen Y; Tian P; Zhao X; Huang B; Wu Y; Wang J; Guan J; Huang L; Li X; Zhang Y; Zhang J
    J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36835899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinical score for predicting left ventricular reverse remodelling in patients with dilated cardiomyopathy.
    Kimura Y; Okumura T; Morimoto R; Kazama S; Shibata N; Oishi H; Araki T; Mizutani T; Kuwayama T; Hiraiwa H; Kondo T; Murohara T
    ESC Heart Fail; 2021 Apr; 8(2):1359-1368. PubMed ID: 33471966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Determinants and Prognosis of Left Ventricular Reverse Remodelling in Non-Ischemic Dilated Cardiomyopathy.
    Díez-López C; Salazar-Mendiguchía J; García-Romero E; Fuentes L; Lupón J; Bayés-Genis A; Manito N; de Antonio M; Moliner P; Zamora E; Catalá-Ruiz P; Caínzos-Achirica M; Comín-Colet J; González-Costello J
    J Cardiovasc Dev Dis; 2022 Jan; 9(1):. PubMed ID: 35050230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dilated cardiomyopathy caused by truncating titin variants: long-term outcomes, arrhythmias, response to treatment and sex differences.
    Vissing CR; Rasmussen TB; Dybro AM; Olesen MS; Pedersen LN; Jensen M; Bundgaard H; Christensen AH
    J Med Genet; 2021 Dec; 58(12):832-841. PubMed ID: 33106378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relations between circulating and myocardial fibrosis-linked microRNAs with left ventricular reverse remodeling in dilated cardiomyopathy.
    Dziewięcka E; Totoń-Żurańska J; Wołkow P; Kołton-Wróż M; Pitera E; Wiśniowska-Śmiałek S; Khachatryan L; Karabinowska A; Szymonowicz M; Podolec P; Rubiś P
    Adv Clin Exp Med; 2020 Mar; 29(3):285-293. PubMed ID: 32207584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High body mass index is a predictor of left ventricular reverse remodelling in heart failure with reduced ejection fraction.
    Cescau A; Van Aelst LNL; Baudet M; Cohen Solal A; Logeart D
    ESC Heart Fail; 2017 Nov; 4(4):686-689. PubMed ID: 28752617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and prognosis implications of long term left ventricular reverse remodeling in patients with dilated cardiomyopathy.
    Ruiz-Zamora I; Rodriguez-Capitan J; Guerrero-Molina A; Morcillo-Hidalgo L; Rodriguez-Bailon I; Gomez-Doblas JJ; de Teresa-Galvan E; Garcia-Pinilla JM
    Int J Cardiol; 2016 Jan; 203():1114-21. PubMed ID: 26651150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Predictive factors of left ventricular reverse remodeling in patients with idiopathic or secondary dilated cardiomyopathy].
    Cai H; Fang Z; Weng Z; Jin X
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Jan; 38(1):81-88. PubMed ID: 33177028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A risk score to predict the absence of left ventricular reverse remodeling: Implications for the timing of ICD implantation in primary prevention.
    Pérez-Rodon J; Galve E; Pérez-Bocanegra C; Soriano-Sánchez T; Recio-Iglesias J; Domingo-Baldrich E; Alzola-Guevara M; Ferreira-González I; Marsal JR; Ribera-Solé A; Gutierrez García-Moreno L; Cruz-Carlos LM; Rivas-Gandara N; Roca-Luque I; Francisco-Pascual J; Evangelista-Masip A; Moya-Mitjans À; García-Dorado D
    J Cardiol; 2018 May; 71(5):505-512. PubMed ID: 29183646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular reverse remodelling predicts long-term outcomes in patients with functional mitral regurgitation undergoing MitraClip therapy: results from a multicentre registry.
    Adamo M; Godino C; Giannini C; Scotti A; Liga R; Curello S; Fiorina C; Chiari E; Chizzola G; Abbenante A; Visco E; Branca L; Fiorelli F; Agricola E; Stella S; Lombardi C; Colombo A; Petronio AS; Metra M; Ettori F
    Eur J Heart Fail; 2019 Feb; 21(2):196-204. PubMed ID: 30549159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left Ventricular Global Longitudinal Strain as a Predictor for Left Ventricular Reverse Remodeling in Dilated Cardiomyopathy.
    Jung IH; Park JH; Lee JA; Kim GS; Lee HY; Byun YS; Kim BO
    J Cardiovasc Imaging; 2020 Apr; 28(2):137-149. PubMed ID: 32233166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Effect of Pulmonary Artery Diameter/Ascending Aorta Diameter Ratio on Left Ventricular Reverse Remodeling in Patients With Dilated Cardiomyopathy.
    Shibata N; Hiraiwa H; Kazama S; Kimura Y; Araki T; Mizutani T; Oishi H; Kuwayama T; Kondo T; Morimoto R; Okumura T; Murohara T
    Circ J; 2022 Jun; 86(7):1102-1112. PubMed ID: 35082187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential predictive value of cardiac mechanics for left ventricular reverse remodelling in dilated cardiomyopathy.
    Kan A; Fang Q; Li S; Liu W; Tao X; Huang K; Hu M; Feng Z; Gong L
    ESC Heart Fail; 2023 Dec; 10(6):3340-3351. PubMed ID: 37697922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between mutation status and left ventricular reverse remodelling in dilated cardiomyopathy.
    Dal Ferro M; Stolfo D; Altinier A; Gigli M; Perrieri M; Ramani F; Barbati G; Pivetta A; Brun F; Monserrat L; Giacca M; Mestroni L; Merlo M; Sinagra G
    Heart; 2017 Nov; 103(21):1704-1710. PubMed ID: 28416588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of left ventricular reverse remodelling and recurrent mitral regurgitation after personalized surgical treatment of patients with non-ischaemic cardiomyopathy and functional mitral regurgitation.
    Petrus AHJ; Tops LF; Timmer E; Versteegh MIM; Dekkers OM; Klautz RJM; Braun J
    Interact Cardiovasc Thorac Surg; 2018 Nov; 27(5):657-663. PubMed ID: 29788278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does left ventricular reverse remodeling influence long-term outcomes in patients with Chagas cardiomyopathy?
    Nakazone MA; Otaviano AP; Machado MN; Bestetti RB
    Cardiol J; 2022; 29(1):44-52. PubMed ID: 32207838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.